Osteoporosis: are healthcare professionals missing an opportunity

Khan, Yusra Habib; Mallhi, Tauqeer Hussain; Sarriff, Azmi; Khan, Amer Hayat

doi:10.1186/2193-1801-2-463

Cited by 6 publications

(6 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Of the 10 GP survey respondents who reported using a screening tool, the FRAX was the most utilised screening tool, with 90% (n = 9) of GP survey respondents selecting this tool. This finding was similar to that seen in a study by Khan et al (2013) where FRAX was the most widely known screening tool among Malaysian GP survey respondents and pharmacists. However, it is important to note that the FRAX tool does not incorporate the number of fractures beyond one fracture, and the ability to add in all fractures would increase the risk profile (Compston et al, 2017).…”

Section: Wellington Gp Osteoporosis Assessment -Screening Toolssupporting

confidence: 90%

“…the key studies identified by the researcher (Blazkova et al, 2010;Chami et al, 2006;Khan et al, 2013;Vytrisalova et al, 2014;Vytrisalova et al, 2017) this study's results should be relatable to future comparable studies. Statistical input and advice were sought regularly throughout this research undertaking.…”

Section: Discussionmentioning

confidence: 77%

“…Unfortunately, no responses were received despite polite follow up email messages. The [36] survey tool utilised for this study was therefore, constructed by utilising the answers described in the relevant research studies for retrospective extrapolation of the answers, stemming from questions that were likely asked, see (Blazkova et al, 2010;Chami et al, 2006;Khan, Mallhi, Sarriff, & Khan, 2013;Vytrisalova et al, 2014;Vytrisalova et al, 2017).…”

Section: Survey Tool Validitymentioning

confidence: 99%

See 2 more Smart Citations

An Exploration of Current Primary Care Practice Regarding Osteoporosis Assessment Following a Low Trauma Wrist Fracture in people aged 50 years and above in Wellington, New Zealand: A Quantitative Survey

Florance¹

View full text Add to dashboard Cite

<p>Osteoporosis remains a major health issue worldwide. The impact of the condition and the fractures that can occur, can have significant debilitating impact and also incur substantial financial costs to healthcare systems. The burden of osteoporosis and the rate of osteoporotic fractures in New Zealand is comparable to other countries such as Australia, the United States and Europe. There is global literature evidence dating back as far as 1960, indicating that a fracture sustained after a simple trip or fall can be an indicator of osteoporosis. There is a need to ensure that fracture patients with a potential osteoporosis diagnosis, receive follow up care for assessment to treat any underlying bone health issue to prevent future fragility fractures, particularly, hip fractures. Due to limited formal literature sources describing the associated New Zealand context, the aim of this research work was to explore current practice for osteoporosis assessment following a fragility wrist fracture in the general practitioner (GP) primary health care setting in Wellington, New Zealand. A quantitative cross-sectional descriptive survey of Wellington GPs was undertaken for this purpose. The reporting of study results were guided by the recommendations detailed within the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement on reporting observational studies (Vandenbroucke et al., 2014). 35 out of 297 GPs from 60 practices in the Wellington region responded to the survey. When describing the local context in Wellington, New Zealand, study results showed that almost three quarters of Wellington GP survey respondents follow up patients who have sustained a potential fragility wrist fracture. The discharge summary was also shown to be a vital part of the communication process between the tertiary and primary health care sectors, acting as a prompt to the GP for further investigation. The single biggest barrier inhibiting processes to enable timely osteoporosis treatment as perceived by GP survey respondents, was lack of public funding, in particular to support availability of diagnostic Dual Energy X-ray Absorptiometry (DEXA) scanning. Other barriers were identified by the GP survey respondents, such as anti-osteoporosis medication side effects, patient compliance to treatment plans and a lack of time within the scheduled consultation to screen patients for osteoporosis. The main educational resources that a large percentage of GP survey respondents independently accessed on a regular basis, were those that were readily available. These included GP guidelines published by “Osteoporosis New Zealand” and possibly other, and online resources such as “Health Pathways” (a best-practice, condition-specific guideline and information resource for primary health care practitioners - https://3d.healthpathways.org.nz). The results also highlighted that most GP survey respondents preferred to take the lead role in the care for patients needing to undergo osteoporosis investigation and treatment. In addition, the GP survey respondents demonstrated a high level of knowledge regarding osteoporosis risk factors. In summary, this study has identified features of practice with regards to osteoporosis assessment following a fragility wrist fracture in the Wellington region. In addition, this study has also enabled identification of specific areas that could be better supported and resourced to assist GP’s in the prevention of secondary fragility fractures. These include highly visible public health campaigns to raise public awareness of osteoporosis and education to GP’s regarding the available screening tools. A significant finding was also that the GP respondents in this study indicated they considered that an important part of their role was responsibility for osteoporosis prevention and treatment. The study results also highlight that despite funding issues, GP survey respondents view osteoporosis prevention and treatment as best placed in the care of the primary health care sector. This is the first New Zealand study that has identified and described the local context around current practice for fragility wrist fracture care within the Wellington GP community, establishing important reference points which can be used to support further development and research.</p>

show abstract

Section: Wellington Gp Osteoporosis Assessment -Screening Toolssupporting

confidence: 90%

Section: Discussionmentioning

confidence: 77%

Section: Survey Tool Validitymentioning

confidence: 99%

See 1 more Smart Citation

An Exploration of Current Primary Care Practice Regarding Osteoporosis Assessment Following a Low Trauma Wrist Fracture in people aged 50 years and above in Wellington, New Zealand: A Quantitative Survey

Florance¹

View full text Add to dashboard Cite

show abstract

“…Such women bear disruption in family relationship, social isolation, anxiety, embarrassment, fatigue, osteoporosis, bone fragility and sleep disturbance. 17,18 These symptoms should be addressed to improve the quality of life during periand post-menopausal phase. 6,19 There are several approaches to manage vasomotor symptoms during peri-menopausal and post-menopausal women.…”

Section: Introductionmentioning

confidence: 99%

Managing Hot Flushes In Menopausal Women: A Review

Mallhi

Khan

et al. 2018

J Coll Physicians Surg Pak

View full text Add to dashboard Cite

Hot flushes during menopause are distressing for women and result in poor quality of life. Purpose of the current review was to evaluate the available treatment modalities that should be utilised for the management of hot flushes. Menopause refers to last menses of women life and can be declared after amenorrhea of 12 months. Vasomotor symptoms including hot flushes and night sweats are common after menopause, affecting almost 50 - 85% women older than 45 years. The mean increment in core body and skin temperature is 0.5°C and 0.25 - 3°C during a hot flush attack. Low level of estrogen during menopause and its association in triggering episodes of hot flushes, is still under debate. The most accepted hypothesis is a narrowing of the thermoneutral zone (TNZ) triggered by estrogen fluctuations. Although, hormone replacement therapy (HRT) remains the standard treatment for the alleviation of such symptoms, incidence of life threatening side effects restrained medical professionals from its use. Complications associated with the use of HRT can be avoided by appropriate evaluation of patients before initiating therapy. Several guidelines have also recommended HRT (estrogen and progesterone) to be safe for up to a period of seven years. Both hormonal and non-hormonal treatments are used for the management of hot flushes. Since hot flushes are the least appreciated and neglected complication of menopause, current review provides detailed information on its background, pathophysiology and management, and emphasises the need of its treatment.

show abstract

“…Scavenging of free radicals by anti-oxidants reduced the process of liver cells fibrosis (Raja et al, 2006). Many plants have been identified as hepatoprotective like Trianthema decandra (Balamurugan and Muthusamy, 2008), Cocculus hirsutus (Thakare et al, 2009), Carica papaya (Sadeque and Begum, 2010), Carissa spinarum (Hegde and Joshi, 2010), Convolvulus arvensis (Ali et al, 2013), Dodonaea viscosa (Khan et al, 2013), Trichodesma sedgwickianum (Saboo et al, 2013), OfIpomoea staphylina (Bag and Mumtaz, 2013) and Khamira Gaozaban Ambri Jadwar Ood Saleeb Wala (Akhtar et al, 2013).…”

Section: Introductionmentioning

confidence: 99%